Zhankui Jia

959 total citations
59 papers, 688 citations indexed

About

Zhankui Jia is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhankui Jia has authored 59 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhankui Jia's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Zhankui Jia is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Zhankui Jia collaborates with scholars based in China, United States and Australia. Zhankui Jia's co-authors include Jinjian Yang, Songchao Li, Zhibo Jin, Zhengguo Zhang, Chaohui Gu, Rui Xue, Fengyan Tian, Jun Wang, Shaojin Zhang and Yiming Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Zhankui Jia

57 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhankui Jia China	17	383	259	147	78	76	59	688
Wei Guan China	17	492 1.3×	237 0.9×	125 0.9×	52 0.7×	102 1.3×	34	887
Jianguo Shi China	16	288 0.8×	154 0.6×	84 0.6×	123 1.6×	91 1.2×	48	605
Weihong Yang China	18	307 0.8×	171 0.7×	70 0.5×	86 1.1×	53 0.7×	49	838
Wei Yuan China	14	234 0.6×	136 0.5×	88 0.6×	89 1.1×	142 1.9×	48	617
Yu Wu China	14	266 0.7×	136 0.5×	181 1.2×	218 2.8×	82 1.1×	57	683
Bolot Mambetsariev United States	13	299 0.8×	123 0.5×	87 0.6×	128 1.6×	117 1.5×	19	739
Xiaoyan Hao China	17	394 1.0×	143 0.6×	76 0.5×	42 0.5×	79 1.0×	67	720
Fusheng Wu China	14	435 1.1×	379 1.5×	49 0.3×	85 1.1×	128 1.7×	24	883
Min Cheol Lee South Korea	15	296 0.8×	128 0.5×	125 0.9×	177 2.3×	49 0.6×	22	612
Yanhua Li China	15	345 0.9×	178 0.7×	47 0.3×	42 0.5×	66 0.9×	33	625

Countries citing papers authored by Zhankui Jia

Since Specialization

Citations

This map shows the geographic impact of Zhankui Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhankui Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhankui Jia more than expected).

Fields of papers citing papers by Zhankui Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhankui Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhankui Jia. The network helps show where Zhankui Jia may publish in the future.

Co-authorship network of co-authors of Zhankui Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Zhankui Jia. A scholar is included among the top collaborators of Zhankui Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhankui Jia. Zhankui Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Ruoyang, Long Zhang, Xiang Li, et al.. (2025). Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells. Journal of Experimental & Clinical Cancer Research. 45(1). 22–22.

Jia, Zhankui, et al.. (2025). Systemic immune inflammatory index and mortality in chronic kidney disease. Frontiers in Endocrinology. 16. 1605543–1605543.

Zhang, Yu, Zihao Wang, Ningyang Li, et al.. (2024). TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression. Journal of Experimental & Clinical Cancer Research. 43(1). 16–16. 9 indexed citations

Zhang, Yu, et al.. (2023). Antibody-drug conjugates in urinary tumors: clinical application, challenge, and perspectives. Frontiers in Oncology. 13. 6 indexed citations

Ning, Xianghui, et al.. (2022). Identification of a Hypoxia-Related Gene Model for Predicting the Prognosis and Formulating the Treatment Strategies in Kidney Renal Clear Cell Carcinoma. Frontiers in Oncology. 11. 806264–806264. 12 indexed citations

Tong, Shijie & Zhankui Jia. (2022). Primary urachal leiomyosarcoma: A rare case report and literature review. Urology Case Reports. 44. 102143–102143. 1 indexed citations

Tang, Bo, Yinhui Yang, Zhaogang Yang, et al.. (2021). MAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression. Cancer Research. 81(17). 4471–4484. 11 indexed citations

Li, Xiang, Zhankui Jia, Chaohui Gu, et al.. (2021). Bioinformatics Analysis of GFAP as a Potential Key Regulator in Different Immune Phenotypes of Prostate Cancer. BioMed Research International. 2021(1). 1466255–1466255. 3 indexed citations

Ning, Xianghui, et al.. (2020). A Three Protein‐Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients. BioMed Research International. 2020(1). 7272960–7272960. 9 indexed citations

10.

Zhang, Lu, Siyuan He, Zhankui Jia, et al.. (2020). Upregulated circPDK1 Promotes RCC Cell Migration and Invasion by Regulating the miR-377-3P-NOTCH1 Axis in Renal Cell Carcinoma. OncoTargets and Therapy. Volume 13. 11237–11252. 24 indexed citations

11.

Wang, Hui, Jinjian Yang, Shiwen Li, et al.. (2018). LncRNA MIAT facilitated BM-MSCs differentiation into endothelial cells and restored erectile dysfunction via targeting miR-200a in a rat model of erectile dysfunction. European Journal of Cell Biology. 97(3). 180–189. 27 indexed citations

12.

Li, Songchao, et al.. (2018). Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1. Cell & Bioscience. 8(1). 9–9. 33 indexed citations

13.

Li, Songchao, et al.. (2018). Single-plane retroperitoneoscopic adrenalectomy: a new operative procedure for benign adrenal disease. Scientific Reports. 8(1). 4027–4027. 2 indexed citations

14.

Lu, Xiaoting, et al.. (2017). [The effect of aluminum trichloride on expression of phosphorylated tau and Aβ in SH-SY5Y cells].. PubMed. 35(5). 359–361. 2 indexed citations

15.

Jin, Zhibo, et al.. (2017). Involvement of interstitial cells of Cajal in bladder dysfunction in mice with experimental autoimmune encephalomyelitis. International Urology and Nephrology. 49(8). 1353–1359. 9 indexed citations

16.

Jia, Zhankui, Rui Xue, Gangqiong Liu, et al.. (2014). HMGB1 Is Involved in the Protective Effect of the PPARαAgonist Fenofibrate against Cardiac Hypertrophy. PPAR Research. 2014. 1–9. 27 indexed citations

17.

Jia, Zhankui, et al.. (2014). Effect comparison of the ingurnal lymphadenectomy with laparoscope operation and open surgery for penile cancer. Zhonghua shiyan waike zazhi. 31(12). 2905–2907. 2 indexed citations

18.

Wang, Jiaxiang, Lei Wang, Da Zhang, et al.. (2011). Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors. Molecular Biology Reports. 39(5). 5095–5104. 17 indexed citations

19.

Herath, Chandana B., et al.. (2009). The role of rage (receptor for advanced glycation endproducts) in hepatic fibrogenesis. Journal of Gastroenterology and Hepatology. 24. 1 indexed citations

20.

Zhang, Song, et al.. (2008). Treatment of Chylothorax with Elemene. The Thoracic and Cardiovascular Surgeon. 56(2). 103–105. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact